Overview

Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

Status:
Completed

Trial end date:
2011-05-01

Target enrollment:

Participant gender:

Summary

The Primary objective was to assess the efficacy of Celivarone for the prevention of Implantable Cardioverter Defibrillator (ICD) interventions or death. Secondary objectives were: - To assess the tolerability and safety of the different dose regimens of Celivarone in the selected population. - To document Celivarone plasma levels during the study.

Phase:

Phase 2

Details

Lead Sponsor:

Sanofi

Treatments:

Amiodarone